Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Statistics

Total Valuation

Orion Pharma has a market cap or net worth of BDT 6.22 billion. The enterprise value is 34.55 billion.

Market Cap	6.22B
Enterprise Value	34.55B

Important Dates

The last earnings date was Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Orion Pharma has 234.00 million shares outstanding.

Current Share Class	234.00M
Shares Outstanding	234.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.07
PB Ratio	0.29
P/TBV Ratio	0.31
P/FCF Ratio	15.53
P/OCF Ratio	7.57
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 77.72, with an EV/FCF ratio of 86.20.

EV / Earnings	-58.04
EV / Sales	11.47
EV / EBITDA	77.72
EV / EBIT	n/a
EV / FCF	86.20

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 1.26.

Current Ratio	2.06
Quick Ratio	1.82
Debt / Equity	1.26
Debt / EBITDA	61.90
Debt / FCF	67.46
Interest Coverage	-0.33

Financial Efficiency

Return on equity (ROE) is -2.98% and return on invested capital (ROIC) is -0.28%.

Return on Equity (ROE)	-2.98%
Return on Assets (ROA)	-0.15%
Return on Invested Capital (ROIC)	-0.28%
Return on Capital Employed (ROCE)	-0.28%
Weighted Average Cost of Capital (WACC)	1.22%
Revenue Per Employee	1.02M
Profits Per Employee	-201,525
Employee Count	2,954
Asset Turnover	0.05
Inventory Turnover	1.41

Taxes

In the past 12 months, Orion Pharma has paid 92.10 million in taxes.

Income Tax	92.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.75% in the last 52 weeks. The beta is -0.54, so Orion Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.54
52-Week Price Change	-7.75%
50-Day Moving Average	28.62
200-Day Moving Average	30.66
Relative Strength Index (RSI)	42.10
Average Volume (20 Days)	238,423

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Pharma had revenue of BDT 3.01 billion and -595.30 million in losses. Loss per share was -2.54.

Revenue	3.01B
Gross Profit	1.09B
Operating Income	-134.87M
Pretax Income	-560.80M
Net Income	-595.30M
EBITDA	424.22M
EBIT	-134.87M
Loss Per Share	-2.54

Balance Sheet

The company has 148.34 million in cash and 27.04 billion in debt, with a net cash position of -26.89 billion or -114.92 per share.

Cash & Cash Equivalents	148.34M
Total Debt	27.04B
Net Cash	-26.89B
Net Cash Per Share	-114.92
Equity (Book Value)	21.43B
Book Value Per Share	85.46
Working Capital	9.00B

Cash Flow

In the last 12 months, operating cash flow was 821.80 million and capital expenditures -421.00 million, giving a free cash flow of 400.80 million.

Operating Cash Flow	821.80M
Capital Expenditures	-421.00M
Depreciation & Amortization	559.09M
Net Borrowing	-341.00M
Free Cash Flow	400.80M
FCF Per Share	1.71

Margins

Gross margin is 36.23%, with operating and profit margins of -4.48% and -19.77%.

Gross Margin	36.23%
Operating Margin	-4.48%
Pretax Margin	-18.62%
Profit Margin	-19.77%
EBITDA Margin	14.09%
EBIT Margin	-4.48%
FCF Margin	13.31%

Dividends & Yields

Orion Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.56%
FCF Yield	6.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 27, 2013. It was a forward split with a ratio of 1.2.

Last Split Date	May 27, 2013
Split Type	Forward
Split Ratio	1.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	4